Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Jacobs

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
The Journal of Rheumatology|August 1, 1991
Auranofin therapy for juvenile rheumatoid arthritis: results of the five-year open label extension trialE H Giannini, K S Barron, C H Spencer, et al.
Arthritis and Rheumatism|February 1, 1986
A study of classification criteria for a diagnosis of juvenile rheumatoid arthritisJ T Cassidy, J E Levinson, J C Bass, et al.
Cancers|June 26, 2026
Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based StudyEline G M Steenhuis, Lieke M van Disseldorp, Femke J C Jacobs, et al.
Journal of Lipid Research|February 5, 2026
Characterization and response to exercise training of high-density lipoprotein-specific phospholipid effluxEric C Leszczynski, Charles S Schwartz, Kiani J C Jacobs, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
The Journal of Rheumatology|August 1, 1991
Auranofin therapy for juvenile rheumatoid arthritis: results of the five-year open label extension trialE H Giannini, K S Barron, C H Spencer, et al.
Arthritis and Rheumatism|February 1, 1986
A study of classification criteria for a diagnosis of juvenile rheumatoid arthritisJ T Cassidy, J E Levinson, J C Bass, et al.
Cancers|June 26, 2026
Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based StudyEline G M Steenhuis, Lieke M van Disseldorp, Femke J C Jacobs, et al.
Journal of Lipid Research|February 5, 2026
Characterization and response to exercise training of high-density lipoprotein-specific phospholipid effluxEric C Leszczynski, Charles S Schwartz, Kiani J C Jacobs, et al.
Pageof 8